Clinical Trial Update: Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial results for IDP-122 topical lotion in moderate-to-severe plaque psoriasis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• IDP-122 Lotion

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-27